These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38217825)

  • 1. Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Abud EM; White AA
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):73-80. PubMed ID: 38217825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
    Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
    Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA
    J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
    Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
    Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T; Kato A; Berdnikovs S; Stevens WW; Suh LA; Norton JE; Carter RG; Harris KE; Peters AT; Hulse KE; Grammer LC; Welch KC; Shintani-Smith S; Tan BK; Conley DB; Kern RC; Bochner BS; Schleimer RP
    J Allergy Clin Immunol; 2017 Sep; 140(3):720-729. PubMed ID: 28238741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.
    Luskin K; Thakrar H; White A
    Immunol Allergy Clin North Am; 2020 May; 40(2):329-343. PubMed ID: 32278455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease.
    Sehanobish E; Asad M; Jerschow E
    Curr Opin Allergy Clin Immunol; 2022 Feb; 22(1):42-48. PubMed ID: 34739410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
    Sohail A; Hacker J; Ryan T; McGill A; Bergmark R; Bhattacharyya N; Lee SE; Maxfield A; Roditi R; Julé AM; Griffith A; Lederer J; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
    Perić A; Gaćeša D; Cvetković G; Vojvodić D
    Immun Inflamm Dis; 2023 Feb; 11(2):e791. PubMed ID: 36840483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on immune mechanisms in aspirin-exacerbated respiratory disease.
    Laidlaw TM; Boyce JA
    J Allergy Clin Immunol; 2023 Feb; 151(2):301-309. PubMed ID: 36184313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in aspirin-exacerbated respiratory disease (AERD)].
    Higashi N; Mitsui C; Taniguchi M
    Nihon Rinsho; 2016 Oct; 74(10):1683-1687. PubMed ID: 30551280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
    Buchheit KM; Lewis E; Gakpo D; Hacker J; Sohail A; Taliaferro F; Berreondo Giron E; Asare C; Vukovic M; Bensko JC; Dwyer DF; Shalek AK; Ordovas-Montanes J; Laidlaw TM
    J Allergy Clin Immunol; 2021 Aug; 148(2):574-584. PubMed ID: 34144111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.